İstatistik

75 methods in this family.

Featured

Accelerated Failure Time ModelThe Accelerated Failure Time model is a parametric regression approach to survival analysis — formally reviewed and advocated by L. J. Wei in 1992 — in which covariates act as mult Adaptive Competing Risks AnalysisAdaptive competing risks analysis combines the Fine-Gray subdistribution hazard framework — which models the cumulative incidence of one cause of failure in the presence of other m Adaptive Cox Proportional HazardsThe Adaptive Cox Proportional Hazards model extends the classic Cox regression for time-to-event outcomes by adding adaptive LASSO (or related) penalization. It simultaneously esti Bayesian Case SeriesBayesian case series is an observational epidemiological method that applies Bayesian inference to case series data — typically records of patients who experienced both a drug or v Bayesian Case-Control StudyA Bayesian case-control study applies Bayesian statistical inference to the classic case-control epidemiological design, formally combining prior knowledge about exposure-disease a Bayesian Case-Crossover DesignThe Bayesian case-crossover design is a self-matched epidemiological method that estimates the transient effect of a time-varying exposure on the risk of an acute event. Each case

Reading path

This topic's most-referenced foundational methods, in the order they were developed — a place to start if you're new here.

Ecological Study19th century (Snow 1854); formalised mid-20th centuryby Various; foundational work by John Snow (1854) and systematised in modern form by Brian MacMahon and colleagues
Kaplan-Meier1958by Kaplan, E. L. & Meier, P.
Kaplan-Meier Analysis1958by Edward L. Kaplan and Paul Meier
Log-Rank Test1966by Mantel, N.
Cox proportional hazards1972by Sir David Roxbee Cox
Cox Regression1972by Cox, D. R.
Bayesian Randomized Clinical Trial1980s–2000s (formal methodology consolidated ~2004–2006)by Donald A. Berry and David J. Spiegelhalter (applied Bayesian inference formally to RCT design)
Clinical Frailty Scale2005by Kenneth Rockwood

all methods on this shelf ↓

All methods 75

Accelerated Failure Time Model Adaptive Competing Risks Analysis Adaptive Cox Proportional Hazards Bayesian Case Series Bayesian Case-Control Study Bayesian Case-Crossover Design Bayesian Cohort Study Bayesian Competing Risks Analysis Bayesian Cox Proportional Hazards Bayesian Diagnostic Accuracy Study Bayesian Dose-Response Analysis Bayesian Ecological Study Bayesian Kaplan-Meier analysis Bayesian nested case-control Bayesian Phase I clinical trial Bayesian Phase II Clinical Trial Bayesian Phase III Clinical Trial Bayesian Phase IV study Bayesian Randomized Clinical Trial Bayesian Screening Test Evaluation Bioequivalence Analysis Cambridge Depersonalisation Scale CAT Clinical Frailty Scale Common Factors Questionnaire Competing Risks Analysis Cox proportional hazards Cox Regression DeepHit DeepSurv Ecological Study Emax Model Frailty Model HIT-6 In Vitro-In Vivo Correlation Joint Model for Longitudinal and Survival Data Kaplan-Meier Kaplan-Meier Analysis Landmark Analysis Log-Rank Test Matched Competing Risks Analysis Matched Cox Proportional Hazards Matched Kaplan-Meier Analysis Matched Survival Analysis Meta-analytic competing risks analysis Meta-analytic Cox proportional hazards Meta-analytic Kaplan-Meier analysis Meta-analytic Phase I clinical trial Mini-BESTest Balance Evaluation Mixture Cure Model Montreal Cognitive Assessment Multi-State Model Multicenter Competing Risks Analysis Multicenter Cox proportional hazards Multicenter Kaplan-Meier analysis Nelson-Aalen Estimator Population Pharmacokinetics Pragmatic Kaplan-Meier analysis Prospective Competing Risks Analysis Prospective Cox proportional hazards Random Survival Forest Recurrent Event Model Retrospective Case Report Retrospective competing risks analysis Retrospective Cox proportional hazards Retrospective Ecological Study Retrospective Kaplan-Meier Analysis Risk-adjusted competing risks analysis Risk-adjusted Cox Proportional Hazards Risk-adjusted Kaplan-Meier analysis Risk-adjusted survival analysis Royston-Parmar Model Therapeutic Drug Monitoring Time-Dependent Cox Regression Weibull Regression

More in Health & Medicine

Yapay Zekâ 1 Karar Bilimleri 30 Ölçme & Psikometri 359 Nedensellik & Kanıt 249